105 related articles for article (PubMed ID: 2529430)
41. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast.
Botti C; Vici P; Lopez M; Scinto AF; Cognetti F; Cavaliere R
J Am Coll Surg; 1995 Sep; 181(3):202-8. PubMed ID: 7670678
[TBL] [Abstract][Full Text] [Related]
42. [Serous Carcinoma of the Peritoneum with Metastases to the Breast and Axillary Lymph Nodes].
Ueda A; Yamamoto D; Tsubota Y; Sueoka N; Yoshikawa K; Kon M
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2252-2254. PubMed ID: 28133286
[TBL] [Abstract][Full Text] [Related]
43. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
44. [Drug concentration in axillary lymph nodes of patients with breast cancer after lymphatic chemotherapy].
Chen JH; Yang YM; Li KZ; Ling R; Yao Q; Yang H
Ai Zheng; 2005 Apr; 24(4):494-7. PubMed ID: 15820077
[TBL] [Abstract][Full Text] [Related]
45. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
46. Coexistence of metastatic breast carcinoma and primary tuberculosis in axillary lymph nodes: a report of a rare case.
Pujani M; Khan S; Hassan MJ; Jetley S; Raina PK
Breast Dis; 2015; 35(3):195-8. PubMed ID: 26406543
[TBL] [Abstract][Full Text] [Related]
47. [Impact of preoperative lymphatic chemotherapy on relapse and metastasis of breast cancer and its mechanism].
Wu WJ; Zeng J; Lu YF; Jiang WZ; Chen L; Pan CE
Ai Zheng; 2005 Dec; 24(12):1537-41. PubMed ID: 16351809
[TBL] [Abstract][Full Text] [Related]
48. Axillary ultrasound for preoperative nodal staging in breast cancer patients: is it of added value?
Schipper RJ; van Roozendaal LM; de Vries B; Pijnappel RM; Beets-Tan RG; Lobbes MB; Smidt ML
Breast; 2013 Dec; 22(6):1108-13. PubMed ID: 24095611
[TBL] [Abstract][Full Text] [Related]
49. Axillary lymph nodes suspicious for breast cancer metastasis: sampling with US-guided 14-gauge core-needle biopsy--clinical experience in 100 patients.
Abe H; Schmidt RA; Kulkarni K; Sennett CA; Mueller JS; Newstead GM
Radiology; 2009 Jan; 250(1):41-9. PubMed ID: 18955508
[TBL] [Abstract][Full Text] [Related]
50. Axillary lymph nodes and serum immunoglobulins in breast cancer.
Lee YT; Richters A
J Am Med Womens Assoc (1972); 1977 Dec; 32(12):455-6, 461-6. PubMed ID: 201690
[No Abstract] [Full Text] [Related]
51. The axillary lymph nodes in breast cancer. Seven years on.
Steele RJ
J R Coll Surg Edinb; 1983 Sep; 28(5):282-91. PubMed ID: 6358482
[No Abstract] [Full Text] [Related]
52. Clinical importance of preoperative detection of the apical lymph node metastasis in patients with breast carcinoma.
Güven HE; Bulak H; Turanli S; Oral S
Singapore Med J; 2007 Jan; 48(1):31-3. PubMed ID: 17245513
[TBL] [Abstract][Full Text] [Related]
53. Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer.
Morton BA; Ramey WG; Paderon H; Miller RE
Cancer Res; 1986 Apr; 46(4 Pt 2):2121-6. PubMed ID: 3081262
[TBL] [Abstract][Full Text] [Related]
54. [Importance of lymph node involvement in breast carcinoma for the oncologist].
Cerny T
Zentralbl Chir; 2000; 125(10):813-6. PubMed ID: 11098575
[TBL] [Abstract][Full Text] [Related]
55. Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging: a feasibility study.
Schipper RJ; Smidt ML; van Roozendaal LM; Castro CJ; de Vries B; Heuts EM; Keymeulen KB; Wildberger JE; Lobbes MB; Beets-Tan RG
Invest Radiol; 2013 Mar; 48(3):134-9. PubMed ID: 23262788
[TBL] [Abstract][Full Text] [Related]
56. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of the tracing effect of carbon nanoparticle and carbon nanoparticle-epirubicin suspension in axillary lymph node dissection for breast cancer treatment.
Du J; Zhang Y; Ming J; Liu J; Zhong L; Liang Q; Fan L; Jiang J
World J Surg Oncol; 2016 Jun; 14(1):164. PubMed ID: 27335011
[TBL] [Abstract][Full Text] [Related]
58. [Histological structure of the primary tumor and status of the regional lymph nodes in breast cancer].
Geppert M; Pawlowski Z
Geburtshilfe Frauenheilkd; 1984 Nov; 44(11):710-4. PubMed ID: 6096200
[TBL] [Abstract][Full Text] [Related]
59. Breast cancer metastasis and lymph node lymphocyte-macrophage interaction.
Richters A
J Surg Oncol; 1980; 13(3):227-30. PubMed ID: 7374157
[TBL] [Abstract][Full Text] [Related]
60. Problems concerning patients' qualification for surgical procedures allowing for evaluation of the condition of axillary fossa lymph nodes in the radical treatment of breast cancer.
Nowikiewicz T; Śrutek E; Zegarski W
Pol Przegl Chir; 2015 Jun; 87(6):290-4. PubMed ID: 26247499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
